Massimo Caruso

Massimo Caruso holds a degree in Biological Sciences (Bio-molecular address) in 2001 with a thesis entitled "Detection of Enterovirus RNA in the first diagnosis of juvenile diabetes" at the University of Catania. He subsequently obtained a PhD in Respiratory Diseases at the Faculty of Medicine and Surgery of the University of Catania with a thesis on the proinflammatory effects of oxidized low-density lipoproteins (LDL) on eosinophilic polymorphonuclear cells (Oxidized Low-Density Lipoproteins Promote Eosinophil Activation). After spending a few years working in a private research and diagnostic laboratory, where he developed a line of research on the pathogenetic mechanisms of allergic reactions, he distinguished himself at the American Academy of Asthma, Allergy and Immunology for his studies on delayed hypersensitivity reactions to drugs, winning the Fellow in Training International Travel grant Scholarship for two years (2012-2014), to present his works at the annual meeting of the scientific society. The same studies led him to obtain a patent for industrial invention: “Method and Kit for in vitro diagnostics of delayed adverse drug reactions”. He returned to the University of Catania in 2013 to coordinate the activities of a new research laboratory (Experimental Immunology) as part of an international project on biomarkers of severe refractory asthma, U-BIOPRED. Since then he has continuously carried out his research activity at the University of Catania studying the biomarkers of asthma and in particular the phenotype of smoking asthmatics. For several years, his main line of research has been the study of biomarkers of cell damage induced by cigarette smoke and "smoke-free" electronic device’s aerosol as an alternative to tobacco smoke.